Upper transversal hepatectomy with double hepatic vein resection and reconstruction to treat colorectal cancer liver metastases at the hepatocaval confluence: a strategy to achieve R0 liver-sparing resection

被引：0

作者：

Lucio Urbani

Nicolò Roffi

Stefano Signori

Riccardo Balestri

Piero Colombatto

Gabriella Licitra

Chiara Leoni

Daniele Meiattini

Roberto Moretto

Chiara Cremolini

Gianluca Masi

Piero Boraschi

Francesca Quilici

Piero Buccianti

Marco Puccini

机构：

[1] Azienda Ospedaliero-Universitaria PisanaOspedale Nuovo Santa Chiara,General Surgery Unit

[2] Cisanello,Hepatology Unit

[3] Azienda Ospedaliero-Universitaria PisanaOspedale Nuovo Santa Chiara,Anaesthesiology and Intensive Care Unit

[4] Cisanello,Oncology Unit

[5] Azienda Ospedaliero-Universitaria PisanaOspedale Nuovo Santa Chiara,Radiology Unit

[6] Cisanello,Pathology Unit

[7] Azienda Ospedaliero-Universitaria PisanaOspedale Nuovo Santa Chiara,undefined

[8] Cisanello,undefined

[9] Azienda Ospedaliero-Universitaria PisanaOspedale Nuovo Santa Chiara,undefined

[10] Cisanello,undefined

[11] Azienda Ospedaliero-Universitaria PisanaOspedale Nuovo Santa Chiara,undefined

[12] Cisanello,undefined

来源：

Langenbeck's Archives of Surgery | 2022年 / 407卷

关键词：

Liver resection; Hepatic vein; Liver metastasis; Parenchyma sparing; Hepatocaval confluence;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1741 / 1750

页数：9

共 50 条

[41] A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases
Jaeck, D
Oussoultzoglou, E
Rosso, E
Greget, M
Weber, JC
Bachellier, P
ANNALS OF SURGERY, 2004, 240 (06) : 1037 - 1051
[42] A multicenter phase II trial to evaluate the efficacy of mFOLFOX6+cetuximab as induction chemotherapy to achieve R0 surgical resection for advanced colorectal liver metastases (NEXTO trial)
Hasegawa, K.
Saiura, A.
Oba, M.
Aosasa, S.
Tanaka, N.
Takayama, T.
Hashiguchi, Y.
Bandai, Y.
Sakamoto, H.
Yamagata, S.
Aoyanagi, N.
Kaneko, H.
Koyama, H.
Miyagawa, S.
Yamamoto, J.
Mise, Y.
Shinozaki, E.
Yoshida, S.
Watanabe, T.
Kokudo, N.
ANNALS OF ONCOLOGY, 2016, 27
[43] A multicenter phase II trial to evaluate the efficacy of mFOLFOX6+cetuximab as induction chemotherapy to achieve R0 surgical resection for advanced colorectal liver metastases (NEXTO trial)
Nishioka, Y.
Hasegawa, K.
Saiura, A.
Oba, M.
Yamamoto, J.
Nomura, Y.
Takayama, T.
Hashiguchi, Y.
Shibasaki, M.
Sakamoto, H.
Yamagata, S.
Aoyanagi, N.
Kaneko, H.
Koyama, H.
Miyagawa, S.
Mise, Y.
Shinozaki, E.
Yoshida, S.
Nozawa, H.
Kokudo, N.
ANNALS OF ONCOLOGY, 2018, 29
[44] A Multicenter Phase 2 Trial to Evaluate the Efficacy of mFOLFOX6 + Cetuximab as Induction Chemotherapy to Achieve R0 Surgical Resection for Advanced Colorectal Liver Metastases (NEXTO Trial)
Yoshihiro Mise
Kiyoshi Hasegawa
Akio Saiura
Masaru Oba
Junji Yamamoto
Yukihiro Nomura
Tadatoshi Takayama
Yojiro Hashiguchi
Masayuki Shibasaki
Hirohiko Sakamoto
Seiichi Yamagata
Nobuyoshi Aoyanagi
Hironori Kaneko
Hiroto Koyama
Shinichi Miyagawa
Eiji Shinozaki
Shuntaro Yoshida
Hiroaki Nozawa
Norihiro Kokudo
Annals of Surgical Oncology, 2020, 27 : 4188 - 4195
[45] A Multicenter Phase 2 Trial to Evaluate the Efficacy of mFOLFOX6+Cetuximab as Induction Chemotherapy to Achieve R0 Surgical Resection for Advanced Colorectal Liver Metastases (NEXTO Trial)
Mise, Yoshihiro
Hasegawa, Kiyoshi
Saiura, Akio
Oba, Masaru
Yamamoto, Junji
Nomura, Yukihiro
Takayama, Tadatoshi
Hashiguchi, Yojiro
Shibasaki, Masayuki
Sakamoto, Hirohiko
Yamagata, Seiichi
Aoyanagi, Nobuyoshi
Kaneko, Hironori
Koyama, Hiroto
Miyagawa, Shinichi
Shinozaki, Eiji
Yoshida, Shuntaro
Nozawa, Hiroaki
Kokudo, Norihiro
ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (11) : 4188 - 4195
[46] Analysis of survival factors after hepatic resection for colorectal cancer liver metastases: Does the R1 margin matter?
Ai, Xiang-nan
Tao, Ming
Wang, Hang-yan
Li, Jing-lin
Sun, Tao
Xiu, Dian-rong
FRONTIERS IN SURGERY, 2023, 9
[47] FOLFOX plus panitumumab or FOLFOX alone as additive therapy following R0/1 resection of RAS wild-type colorectal cancer liver metastases - The PARLIM trial (AIO KRK 0314)
Modest, Dominik Paul
Karthaus, Meinolf
Kasper, Stefan
Moosmann, Nicolas
Keitel, Verena
Kiani, Alexander
Uhlig, Jens
Jacobasch, Lutz
Weikersthal, Ludwig Fischer, V
Fuchs, Martin
Kaiser, Florian
Lerchenmueller, Christian
Sent, Dagmar
Junghanss, Christian
Held, Swantje
Lorenzen, Sylvie
Kaczirek, Klaus
Jung, Andreas
Stintzing, Sebastian
Heinemann, Volker
EUROPEAN JOURNAL OF CANCER, 2022, 173 : 297 - 306
[48] FOLFOX plus panitumumab or FOLFOX alone as additive therapy following R0/1 resection of RAS wild-type colorectal cancer liver metastases: The PARLIM trial (AIO KRK 0314).
Modest, Dominik Paul
Karthaus, Meinolf
Kasper, Stefan
Moosmann, Nicolas
Keitel, Verena
Kiani, Alexander
von Weikersthal, Ludwig Fischer
Uhlig, Jens
Jacobasch, Lutz
Fuchs, Martin
Kaiser, Florian
Lerchenmueller, Christian A.
Junghanss, Christian
Held, Swantje
Heinrich, Kathrin
Jung, Andreas
Stahler, Arndt
Stintzing, Sebastian
Heinemann, Volker
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[49] Repeated versus single dose anti-CEA radioimmunotherapy (RIT) with iodine-131-labetuzumab after R0 resection for colorectal liver metastases (CRC-LM)
Sahlmann, C-O
Liersch, T.
Niessner, M.
Becker, H.
Goldenberg, D. M.
Meller, J.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2008, 23 (04) : 524 - 524
[50] The therapeutic strategy for advanced gastric cancer with pyloric stenosis and liver metastasis; successfully treated by gastro-jejunal bypass and chemotherapy first, followed by curative R0 resection
Naosuke Nakamichi
Masahiro Tsujiura
Tomohiro Matsui
Taiga Yamamoto
Ayana Yoshioka
Hidekazu Hiramoto
Yoshimi Ouchi
Takeshi Ishimoto
Toshiyuki Kosuga
Satoshi Mochizuki
Susumu Nakashima
Masamichi Bamba
Mamoru Masuyama
Eigo Otsuji
Surgical Case Reports, 7

← 1 2 3 4 5 →